Showing results (201-210 of 609) with videos related to
Sort By:
Pageof 61
Academic Medicine : Journal of the Association of American Medical Colleges|January 31, 2023
The Brain Medicine Fellowship: A Competency-Based Training Program to Treat Complex Brain DisordersSarah Levitt, Alex Henri-Bhargava, David B Hogan, et al.Frontiers in Psychiatry|October 5, 2023
The Montreal model: an integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depressionNicolas Garel, Jessica Drury, Julien Thibault Lévesque, et al.Biological Psychiatry|August 10, 2010
A meta-analysis of cytokines in Alzheimer's diseaseWalter Swardfager, Krista Lanctôt, Lana Rothenburg, et al.CNS Drugs|January 10, 2022
Pharmacological Management of Apathy in DementiaLaiba Azhar, Raphael W Kusumo, Giovanni Marotta, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 26, 2018
Biomarkers of agitation and aggression in Alzheimer's disease: A systematic reviewMyuri Ruthirakuhan, Krista L Lanctôt, Matteo Di Scipio, et al.BMC Geriatrics|December 16, 2011
Exposure to general anesthesia and risk of Alzheimer's disease: a systematic review and meta-analysisDallas P Seitz, Prakesh S Shah, Nathan Herrmann, et al.Journal of Alzheimer'S Disease : JAD|February 19, 2016
Apathy and Attentional Biases in Alzheimer's DiseaseSarah A Chau, Jonathan Chung, Nathan Herrmann, et al.The Yale Journal of Biology and Medicine|March 30, 2019
Sleep and Attention in Alzheimer's DiseaseMirna Hennawy, Solomon Sabovich, Celina S Liu, et al.Drugs & Aging|February 22, 2012
Does pharmacological treatment of neuropsychiatric symptoms in Alzheimer's disease relieve caregiver burden?Karen Levy, Krista L Lanctôt, Shale B Farber, et al.International Journal of Geriatric Psychiatry|July 22, 2005
Antipsychotic use in the elderly: shifting trends and increasing costsMark Rapoport, Muhammad Mamdani, Kenneth I Shulman, et al.Pageof 61